The historical rank and industry rank for Fisher & Paykel Healthcare's Net Margin % or its related term are showing as below:
FRA:FPLB'
s Net Margin % Range Over the Past 10 Years
Min: 7.54 Med: 20.01 Max: 29.46
Current: 20.3
FRA:FPLB's Net Margin % is ranked better than 89.35% of 817
companies
in the Medical Devices & Instruments industry
Industry Median: 2.07
vs FRA:FPLB: 20.30
Fisher & Paykel Healthcare (FRA:FPLB) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Fisher & Paykel Healthcare Net Margin % Related Terms
Fisher & Paykel Healthcare Net Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:FPLB vs ISRG, BDX, MDLN: Net Margin % Comparison
For the Medical Instruments & Supplies subindustry, Fisher & Paykel Healthcare's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fisher & Paykel Healthcare Net Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Fisher & Paykel Healthcare's Net Margin % distribution charts can be found below:
* The bar in red indicates where Fisher & Paykel Healthcare's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fisher & Paykel Healthcare (FRA:FPLB) has a Net Margin % of 21.15% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Fisher & Paykel Healthcare and its competitors. This is near median its historical median of 20.01. Over the past decade, Fisher & Paykel Healthcare's Net Margin % has ranged from 7.54 to 29.46. According to the industry distribution chart, Fisher & Paykel Healthcare ranks #87 out of 817 companies in the Medical Devices & Instruments industry, placing it in the top 10.6%.
Is Fisher & Paykel Healthcare's Net Margin % too high?
Fisher & Paykel Healthcare's current Net Margin % of 21.15% is near median its 10-year median of 20.01. Over the past 10 years, this metric has ranged from a low of 7.54 to a high of 29.46. The Medical Devices & Instruments industry median Net Margin % is 2.07. Fisher & Paykel Healthcare's value of 21.15% is 921.7% above this industry median. Based on the distribution chart, Fisher & Paykel Healthcare ranks #87 out of 817 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Fisher & Paykel Healthcare has a GF Score™ of 91/100, reflecting its overall financial health beyond just this single metric.
How does Fisher & Paykel Healthcare's Net Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Fisher & Paykel Healthcare ranks #87 out of 817 companies for Net Margin %. This places Fisher & Paykel Healthcare in the top 11% of its industry — outperforming the majority of peers. The industry median Net Margin % is 2.07. Fisher & Paykel Healthcare's value of 21.15% is 921.7% above this benchmark. Historically, Fisher & Paykel Healthcare's own Net Margin % has ranged from 7.54 to 29.46 over the past decade. While the company's 10-year median is 20.01 vs. the industry median of 2.07, Fisher & Paykel Healthcare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Devices & Instruments company?
The median Net Margin % among Medical Devices & Instruments companies is 2.07, based on 817 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Fisher & Paykel Healthcare's current Net Margin % of 21.15% is 921.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Fisher & Paykel Healthcare and its competitors. For the Medical Devices & Instruments industry, the median Net Margin % is 2.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fisher & Paykel Healthcare's current Net Margin % is 21.15%, which is near median its own 10-year median of 20.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fisher & Paykel Healthcare stock overvalued right now?
Fisher & Paykel Healthcare (FRA:FPLB) has a current Net Margin % of 21.15%. The stock's GF Value™ is €21.23, compared to a current price of €18.40 — trading 13.3% below its estimated fair value. The current Net Margin % is 21.15%, which is near median its 10-year median of 20.01 and 921.7% above the Medical Devices & Instruments industry median of 2.07. Fisher & Paykel Healthcare's overall GF Score™ is 91/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Fisher & Paykel Healthcare (FRA:FPLB), the current Net Margin % is 21.15% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fisher & Paykel Healthcare (FRA:FPLB) Overvalued in 2026?
Based on GuruFocus' analysis, Fisher & Paykel Healthcare stock appears to be undervalued.
The current stock price of €18.40 is trading 13.3% below its estimated GF Value™ of €21.23.
Key valuation signals for FRA:FPLB:
Net Margin %: 21.15% (near median its 10-year median of 20.01)
GF Value™: €21.23 vs. price of €18.40 (13.3% below fair value)
Industry Position: 921.7% above the Medical Devices & Instruments median (#87 of 817)
No single metric tells the full story. See the FRA:FPLB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Fisher & Paykel Healthcare is one of the three largest respiratory care device companies globally. It is the market leader in hospital use of humidifiers, masks, and related consumables, and the number three player in the at-home treatment of sleep apnea using respiratory devices. Both the hospital and homecare markets for respiratory devices are growing strongly in the developed markets in which Fisher & Paykel has a presence. The company earns roughly half of its revenue in North America, around a quarter in Europe, and approximately a fifth in Asia-Pacific. Fisher conducts its own R&D and has thousands of patents and pending applications. It manufactures in New Zealand, Mexico, and China, and has a multichannel distribution model.
91GF Score
Get the complete analysis for FRA:FPLB
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:FPLB has been successfully added to your 
